What is dolichoectasia (a condition characterized by the dilation and elongation of arteries)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Dolichoectasia is a condition characterized by the abnormal enlargement, elongation, and tortuosity of arteries, most commonly affecting the blood vessels at the base of the brain, specifically the vertebrobasilar system, as described in the 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack 1.

Definition and Characteristics

Dolichoectasia is associated with traditional ischemic stroke risk factors such as increasing age, hypertension, and male sex, although its relationship to atherosclerotic disease is less clear 1. The condition develops gradually over time due to weakening of the arterial walls, often related to atherosclerosis, hypertension, or congenital factors.

Clinical Presentation

Patients with dolichoectasia may experience various neurological symptoms including headaches, dizziness, visual disturbances, facial pain or numbness, difficulty swallowing, and in some cases, stroke or transient ischemic attacks.

Diagnosis and Treatment

The diagnosis is typically made through imaging studies such as MRI, MRA, CT angiography, or conventional angiography.

  • Treatment focuses on managing underlying conditions like hypertension and atherosclerosis, using medications such as antihypertensives and statins.
  • In patients with vertebrobasilar dolichoectasia and a history of ischemic stroke or TIA without other attributable causes, the use of antiplatelet or anticoagulant therapy is reasonable for the prevention of recurrent ischemic events, as recommended by the 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack 1.

Management Considerations

In severe cases with complications like compression of cranial nerves or risk of rupture, surgical interventions might be considered, though these carry significant risks due to the complex anatomy involved.

From the Research

Definition and Characteristics of Dolichoectasia

  • Dolichoectasia is an arterial disease that causes dilatation and/or tortuosity of the affected vessel 2.
  • It is characterized by marked elongation, widening, and tortuosity of arteries, with the intracranial vertebral and basilar arteries being preferentially involved 3.
  • Dolichoectatic arteries usually have an abnormally large external diameter and a thin arterial wall, with degeneration of the internal elastic lamina, multiple gaps in the internal elastica, thinning of the media secondary to reticular fiber deficiency, and smooth muscle atrophy 3.

Clinical Presentations and Risks

  • Dolichoectasia commonly presents with ischemic or hemorrhagic stroke, and/or cranial neuropathies 2.
  • The posterior circulation is more frequently affected by the dolichoectatic process than the anterior circulation 2.
  • Dolichoectasia is associated with a high risk of mortality and morbidity, with progressive enlargement of arterial size being a predictor of mortality 4.
  • Patients with dolichoectasia are also at risk of vascular death, recurrent strokes, compressive symptoms, cardiac ischemic disease, and aortic aneurysms 5.

Diagnosis and Treatment

  • A positive diagnosis of dolichoectasia requires visual assessment of vessel shape and, if the posterior circulation is affected, application of Smoker's criteria 2.
  • Reproducible criteria that aid diagnosis of dolichoectasia in the anterior circulation are lacking 2.
  • There is no specific treatment for dolichoectasia, and the surgical and medical therapies that have been used to treat this condition have not been systematically evaluated 2, 4.
  • Therapeutic interventions aimed at slowing down arterial dilatation and preventing thrombosis, such as the use of doxycycline and apixaban, have been proposed, but more evidence is needed to determine their effectiveness 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dolichoectasia-an evolving arterial disease.

Nature reviews. Neurology, 2011

Research

Vertebrobasilar dilatative arteriopathy (dolichoectasia).

Annals of the New York Academy of Sciences, 2010

Research

Dolichoectasia: a brain arterial disease with an elusive treatment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.